openPR Logo
Press release

Obesity Management Market Report 2018: Segmentation by Prescription (Weight-loss Medication (orlistat (Xenical), lorcaserin (Belviq), phentermine and topiramate (Qsymia), buproprion and naltrexone (Contrave), liraglutide (Saxenda), Others) by Surgery (Gas

Obesity Management Market

Obesity Management Market

Global Obesity Management market research report provides company profile for Pfizer Inc. (US), Merck Sharp & Dohme Corp., Merck & Co., Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), GlaxoSmithKline plc. (UK), AstraZeneca (UK), Herbalife Ltd. (U.S.), Apollo Endosurgery (U.S.) and Others.

This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation on the basis of product type, application, end user and regional segmentation. The regional segment is further bifurcated on country level.

Obesity management Market is growing moderately. Changing lifestyle and unhealthy eating habits are leading to the problem of obesity. The population of obese people are increasing globally. Obesity leads to various diseases such as diabetes, hypertension, heart diseases and many others. Drugs manufacturers investing their money in R&D to develop effective anti-obesity drugs. Earlier obesity was considered as problem of high income countries but now it’s shifting towards low-middle income countries. Healthcare solution providers are developing new and innovative solutions for healthcare sector. Hospitals also providing different surgery options according to medical history and condition of the patient.

Request for Free sample copy of ready Report @

Report Coverage:
Top Manufactures/vendors of Obesity Management market:
GlaxoSmithKline plc. (UK)
AstraZeneca (UK)
Herbalife Ltd. (U.S.)
Apollo Endosurgery (U.S.)
Pfizer Inc. (US)
Merck Sharp & Dohme Corp.
Merck & Co., Inc. (US)
F. Hoffmann-La Roche Ltd (Switzerland)
Others (Note: We can profile additional players without any additional charges)

Obesity Management Prescription Type:
Weight-loss Medication (orlistat (Xenical)
lorcaserin (Belviq)
phentermine and topiramate (Qsymia)
buproprion and naltrexone (Contrave)
liraglutide (Saxenda)

Surgery of Obesity Management:
Gastric Bypass Surgery
Laparoscopic Adjustable Gastric Banding (LAGB)
Biliopancreatic Diversion with Duodenal Switch

Obesity Management Lifestyle changes Type:
Dietary Changes

Regions covered in Obesity Management Market Research Report:
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Others)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Others)
South America (Brazil, Argentina, Columbia and Others)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Others)
(Note: We can provide country or region specific report on request; please contact us for your specific requirement)

The Global Obesity Management Market analysis report covers detailed value chain analysis of Global Obesity Management Market. The value chain analysis helps to analyze major upstream raw materials, major equipment’s, manufacturing process, downstream customer analysis and major distributor analysis.
The report also covers in-depth description, competitive scenario, wide product portfolio of prime players active in this market and business strategies adopted by competitors along with their SWOT analysis. The report also provides Porter analysis, PESTEL analysis and market attractiveness which helps to better understand the market scenario on macro and micro level. Side by side, it also explicitly provides information about mergers, acquisitions, joint ventures, and all the other important activities occurred in the market during current and past few years. The Global Obesity Management Market report explores manufacturer’s competitive scenario and provides market share for all major players of this market based on production capacity, sales, revenue, geographical presence and other major factors. The report also covers import/export data across all major regions covered in this report. Moreover, we can exclusively provide information about import/export data across any particular country as per requirement.

How helpful this report will be?
• Obesity Management Market share (regional, product, application, end-user) both in terms of volume and revenue along with CAGR from 2018 to 2025
• Key parameters which are driving this market and restraining its growth
• What all challenges manufacturers will face as well as new opportunities and threats faced by them

Enquire before Buying @

Table of Content:
1. Report Prologue
2. Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
2.4. Market Segmentation........................Continue (

What does Report Include?
Historic Data: What was the Obesity Management Market data (Size, competition, company share, YoY growth rate, etc.) from 2013 to 2018.
Current Market Status: A comprehensive analysis of current market Size, trends, growth drivers, industry pitfalls, challenges and opportunities for players.
Market Forecast: Report will comment and provide details about market growth and forecast till year 2025.
Customization: We can provide following things 1) On request more company profiles (competitors) 2) Data about particular country or region 3) We will incorporate the same with no additional cost (Post conducting feasibility).

Contact Us
Jason Smith,
Sales Manager, Global Business Development,
Contact us: +1-312-376-8303
Address: 20 N State Street, Chicago, Illinois, 60602 United States

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Obesity Management Market Report 2018: Segmentation by Prescription (Weight-loss Medication (orlistat (Xenical), lorcaserin (Belviq), phentermine and topiramate (Qsymia), buproprion and naltrexone (Contrave), liraglutide (Saxenda), Others) by Surgery (Gas here

News-ID: 1386064 • Views: 1280

More Releases for Merck

Recombinant Human Interferon Market to Witness Huge Growth by Key Players: Roche …
The Recombinant Human Interferon report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a robust research methodology model that helps to make informed decisions. It obtains both qualitative and quantitative market information supported by primary research. The Recombinant Human Interferon research report recognizes and
Nanobodies Market to See Booming Growth 2021-2028 | Novo Nordisk A/S, Merck & Co …
𝐍𝐚𝐧𝐨𝐛𝐨𝐝𝐢𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 top level players are analyzed in report based on current and future development status, and Nanobodies market estimations from 2021 to 2028 in terms of revenue and volume. This report provides strategic recommendations consulted by the industrial experts including market share worldwide, future outlook, cost profit structure, supply, raw materials, labour cost, manufacturing expenses, latest market trends, demands, ROI. The Nanobodies market report analyse the manufacturing cost of the
How Epigenomics Market Will Dominate In Coming Years? Key Players: Thermo Fisher …
Fortune Business Insights foresees the pharmaceutical segment to dominate the global epigenomics market on account of the increasing prevalence of chronic diseases such as cancer. According to the World Health Organization (WHO), by the end of 2025, the number of cancer patients will reach 21,471,996. Sample PDF Brochure The increasing prevalence of chronic diseases such as cancer is helping the global epigenomics market to emerge with remarkable market figures, finds
Global Immune Checkpoint Inhibitors Market 2026 : Bristol-Myers Squibb, AstraZen …
Researchmoz added latest report "Global Market Study on Immune Checkpoint Inhibitors: Programmed Death Protein 1 (PD-1) Drug Class to Dominate in Terms of Value Through 2026". The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market. Persistence Market Research (PMR) offers an 8-year forecast on the global immune checkpoint inhibitors market. The primary objective of the report is to offer
Pharmaceuticals Excipients Market 2018 Global Analysis By Key Players – Ashlan …
Summary adds “Pharmaceuticals Excipients Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database. This report provides in depth study of “Pharmaceuticals Excipients Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Pharmaceuticals Excipients Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as
Pneumonia Vaccine Market- GlaxoSmithKline, Pfizer, Merck
Global Pneumonia Vaccine Market Size, Status and Forecast 2022 provides Market information about Manufacturers, Countries, Type and Application.This Industry report also states Company Profile, sales, Pneumonia Vaccine Market revenue and price, market share, market growth and gross margin by regions. Top Manufacturers/Key Players:- GlaxoSmithKline Pfizer Merck Enquiry for buying report @ The Global Pneumonia Vaccine report gives a thorough situation of the present and gauge Pneumonia Vaccine showcase procedures, improvement methodologies and development openings.